Decay-Accelerating Factor Expression Modulates the Severity of Experimental Focal Segmental Glomerulosclerosis [0.03%]
衰加速因子的表达调控实验性局灶节段性肾小球硬化症的严重程度
Sofia Bin,Kelly Budge,Micaela Gentile et al.
Sofia Bin et al.
Genetically induced decay-accelerating factor (DAF) overexpression prevents adriamycin (ADR)-induced focal segmental glomerulosclerosis (FSGS) in mice.Pharmacologic inhibition of DAF cleavage reduces complement activation in the glomeruli a...
COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry [0.03%]
新冠肺炎疫苗与新发原发性肾小球疾病：来自IRocGN2国际注册中心的结果
Meryl Waldman,Ninet Sinaii,Edgar V Lerma et al.
Meryl Waldman et al.
Key Points: IgAN and MCD are the most common de novo glomerular diseases reported after COVID-19 vaccination, particularly after mRNA vaccination.Membranous nephropathy, pauci-immune GN, and collapsing GN have also been ...
Auda M Plaud Gonzalez,Catherine Joseph,Samantha R Stover et al.
Auda M Plaud Gonzalez et al.
Key Points: Specialized fetal centers see a highly complex subset of patients with CAKUT with a predominance of complex or syndromic disease.The mortality rate for fetuses with complex developmental anomalies and CAKUTs ...
Health Care Resource Utilization and Costs of Persistent Severe Acute Kidney Injury (PS-AKI) Among Hospitalized Stage 2/3 AKI Patients [0.03%]
住院治疗的2/3期急性肾损伤(AKI)患者中持续性严重急性肾损伤(PS-AKI)的医疗资源利用和成本
Jay L Koyner,Rachel H Mackey,Ning A Rosenthal et al.
Jay L Koyner et al.
Key Points: Among hospitalized patients with stage 2/3 AKI, persistent severe acute kidney injury (PS-AKI) is associated with significantly longer length of stay (LOS) and higher costs during index hospitalization and 30...
Risk and Timing of De Novo Sepsis in Critically Ill Children after Acute Kidney Injury [0.03%]
急性肾损伤后危重儿童新发全身炎症反应的风险及时间模式研究
Cassandra L Formeck,Robert Feldman,Andrew D Althouse et al.
Cassandra L Formeck et al.
Key Points: Critically ill children who developed AKI have a 42% increase in the probability of developing subsequent hospital-acquired sepsis when compared with children without AKI.When evaluating risk of sepsis over t...
Midodrine Is an Effective Therapy for Resistant Intradialytic Hypotension: COMMENTARY [0.03%]
米多君能够有效治疗顽固性透析低血压：述评
Jackson P Kim,Tara I Chang
Jackson P Kim
Midodrine Is an Effective Therapy for Resistant Intradialytic Hypotension: CON [0.03%]
米多君是难治性透析低血压的有效疗法：反对意见
Kathryn Husarek,Steven M Brunelli
Kathryn Husarek
Midodrine Is an Effective Therapy for Resistant Intradialytic Hypotension: PRO [0.03%]
米多君能有效治疗顽固性透析低血压：一项队列研究
Andrew A House,Christopher W McIntyre
Andrew A House
Matthew B Lanktree
Matthew B Lanktree
New Onset Glomerular Disease Post-COVID-19 Vaccination: Is There a Link? [0.03%]
接种新冠疫苗后新发的肾小球疾病：有关联吗？
Yeshwanter Radhakrishnan,Ladan Zand
Yeshwanter Radhakrishnan